Juvenescence is a life sciences company developing therapies to modify aging and increase healthy human lifespan. The Juvenescence team consists of highly experienced drug developers, entrepreneurs, marketers, and investors with a significant history of success in pharmaceutical drug development, synthetic biology, and tissue and cellular engineering. Juvenescence has a broad pipeline in development and is driving innovation, with a focus on discovering and developing these therapies to modify the aging process, through prevention and by regenerating damage, to support healthy aging and increase health span.
| Website | https://www.juvlabs.com |
| Revenue | $5.7 million |
| Employees | 40 (27 on RocketReach) |
| Founded | 2016 |
| Phone | +44 1624 639396 |
| Technologies | |
| Industry | Biotechnology, Biopharma, Health Care, Science and Engineering, Pharmaceutical |
| Keywords | Aging Research, Life Extension, Lifespan Extension, Longevity Therapies, Anti-Aging Treatments, Senolytics, Drug Development, Healthspan, Innovative Therapies, Geroscience, Regenerative Medicine, Therapeutic Interventions, Biotechnology, Clinical Trials, Pharmaceutical Research, Cellular Senescence, Aging Biomarkers, Biomarkers Of Aging |
Looking for a particular Juvenescence™️ employee's phone or email?
Juvenescence™️ Questions
The Juvenescence™️ annual revenue was $5.7 million in 2026.
Gerson Montenegro is the Chief Operating Officer - COO of Juvenescence™️.
27 people are employed at Juvenescence™️.
Top Juvenescence™️ Employees
-
Gerson Montenegro
Chief Operating Officer - COO at Juvenescence™️
Princeton, NJ, US13 -
Richard Marshall
Chief Executive Officer at Juvenescence™️
United Kingdom -
Tod Henjes
President Juv Life at Juvenescence™️
Doylestown, PA, US15+ -
Alexander Pickett
Managing Director at Juvenescence™️
Marblehead, MA, US24 -
21
-
Gill Dines
Chief Scientific Officer (CSO) at Juvenescence™️
United Kingdom12 -
Joe McCarthy
Chief Brand Officer at Juvenescence™️
Princeton, NJ, US -
1
Related Companies
